Skip to main content
Premium Trial:

Request an Annual Quote

Bernhard Scholkopf

Premium

Health Discovery Corp. (formerly Direct Wireless Communications) has appointed Bernhard Scholkopf to its scientific advisory board. Scholkopf is a director at the Max Plank Institute for Biological Cybernetics in Tubingen, Germany, and was recently appointed Honorary professor for machine learning at the Technical University in Berlin. Scholkolf has also worked as a research scientist at AT&T Bell Labs, GMD-First in Germany, Australian National University, and Microsoft Research in the UK, according to Health Discovery.

Filed under

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.